vTv Therapeutics (VTVT) Return on Capital Employed Growth (5y) (2020 - 2026)

vTv Therapeutics (VTVT) Return on Capital Employed Growth (5y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 vTv Therapeutics 19.21 Mn 19.21 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 8,593.00
Dec 31, 2025 22,452.00
Sep 30, 2025 365,334.00
Jun 30, 2025 -104,915.00
Mar 31, 2025 -71,960.00
Dec 31, 2024 -56,705.00
Sep 30, 2024 -33,940.00
Jun 30, 2024 -20,276.00
Mar 31, 2024 -31,837.00
Dec 31, 2023 -130,422.00
Sep 30, 2023 -55,093.00
Jun 30, 2023 -39,660.00
Mar 31, 2023 -94,217.00
Dec 31, 2022 -545,907.00
Sep 30, 2022 19,431.00
Jun 30, 2022 4,900.00
Mar 31, 2022 -9,853.00
Dec 31, 2021 1,890.00
Sep 30, 2021 6,378.00
Jun 30, 2021 655.00